DRISTAN NASAL MIST 0.5 %
PHENYLEPHRINE HYDROCHLORIDE : 0.5 % PHENIRAMINE MALEATE : 0.2 % · DIN 01929313 · FOUNDATION CONSUMER BRANDS, LLC
Health Canada status: CANCELLED POST MARKET
What is DRISTAN NASAL MIST?
DRISTAN NASAL MIST 0.5 % contains PHENYLEPHRINE HYDROCHLORIDE : 0.5 % PHENIRAMINE MALEATE : 0.2 %. It is listed in the Health Canada Drug Product Database under DIN 01929313, held by FOUNDATION CONSUMER BRANDS, LLC, supplied as SPRAY for NASAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Oct-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01929313 |
|---|---|
| Brand name | DRISTAN NASAL MIST |
| Generic / active ingredient | PHENYLEPHRINE HYDROCHLORIDE : 0.5 % PHENIRAMINE MALEATE : 0.2 % |
| Manufacturer | FOUNDATION CONSUMER BRANDS, LLC |
| Strength | 0.5 % |
| Dosage form | SPRAY |
| Route of administration | NASAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01AB01 PHENYLEPHRINE |
| AHFS class | 52:32.00 ; 04:04.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Oct-2023 |
| Original market date | 1992-12-31 00:00:00 |
Is PHENYLEPHRINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code R01AB01 PHENYLEPHRINE. 1 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| SOFRAMYCIN NASAL SPRAY | 0.05 MG | SPRAY | SEARCHLIGHT PHARMA INC | MARKETED | DIN 02224860 |
| DRISTAN MENTHOLATED NASAL SPRAY | 0.2 % | SPRAY | WYETH CONSUMER HEALTHCARE INC. | CANCELLED POST MARKET | DIN 01929321 |
| NEO SYNEPHRINE NASAL SPRAY | .1 % | SPRAY | STERLING WINTHROP INC. | CANCELLED POST MARKET | DIN 01928538 |
| NEO-SYNEPHRINE NASAL SPRAY | .1 % | SPRAY | BAYER INC CONSUMER CARE | CANCELLED POST MARKET | DIN 02150565 |
| SOFRAMYCIN NASAL SPRAY | 2.5 MG | SPRAY | ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 00173584 |
| SOFRAMYCIN NASAL SPRAY | 2.5 MG | SPRAY | HOECHST ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 01987690 |
Who else supplies PHENYLEPHRINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PHENYLEPHRINE appears in 51 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.